Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

121.25
Delayed Data
As of Mar 30
 +0.91 / +0.76%
Today’s Change
59.79
Today|||52-Week Range
136.33
+2.06%
Year-to-Date

Stock Price Forecast

The 25 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 131.00, with a high estimate of 200.00 and a low estimate of 85.00. The median estimate represents a +8.04% increase from the last price of 121.25.

Analyst Recommendations

The current consensus among 29 polled investment analysts is to Hold stock in Vertex Pharmaceuticals Inc. This rating has held steady since March, when it was downgraded from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.73
Sales
$142.3M
Reporting Date
May 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 1.49%
 
 
 
 
 
 
Growthannually 52.41%
 
 
 
 
 
 

Sales

Growthquarterly -1.54%
 
 
 
 
 
 
Growthannually 83.05%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account